Landscapes / Targets

TIGIT

12 drugs act on TIGIT, in 65 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs12

DrugHow it worksCompanyStageNext dateDetails
TIGIT antibody
GSK +1
Phase 3 31 Dec 2026Phase 1 trial completes
Monoclonal antibody
Roche · Public ROG.SW
Phase 3 31 Dec 2026Phase 2 trial completes
TIGIT antibody
Arcus Biosciences +1 · Public GILD
Phase 3 Mar 2027Phase 2 trial completes
—
Phase 3 Apr 2027Phase 1/2 trial completes
PD-1/TIGIT bispecific antibody
AstraZeneca · Public AZN
Phase 3 4 May 2027Phase 2 trial completes
—
Henlius · Public 2696.HK
Phase 2 10 Feb 2027Phase 2 trial completes
—
Akeso · Public 9926.HK
Phase 2 May 2027Phase 1/2 trial completes
Monoclonal antibody
Merck & Co. · Public MRK
Phase 1/2 13 Feb 2032Phase 1/2 trial completes
—
Huahai Pharmaceutical (Huaota) · Public 600521.SS
Phase 1/2 —
—
Phase 2 —
—
BioNTech · Public BNTX
Phase 1/2 —
—
Phase 1 12 Nov 2027Phase 1 trial completes

About this list

Checked
12 of 12 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow TIGIT

Following is part of Solo: you see every change to TIGIT the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in